Skip to main content

Nanomedicine: New Challenges and Opportunities in Cancer Therapy

Buy Article:

$113.00 plus tax (Refund Policy)


Nanomedicine contribution to cancer therapy is notoriously improving survival and quality of life of cancer patients. Currently there are several products already available on the market, and many others are in the preclinical-to clinical pipeline. Nanomedicine could bring the tools necessary to improve inherent limitations of classical pharmacotherapy. In this review, we offer a comprehensive analysis of the progress made in the design of biodegradable nanocarriers particularly adapted for the delivery of anticancer drugs, including classical low molecular weight drugs, peptides and nucleic acid based therapeutics. Furthermore, we analyze the benefits provided by these drug delivery platforms, such as improving the long-term stability, injectability, biodistribution and efficacy of anticancer drugs.


Document Type: Review Article


Publication date: 2008-09-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more